(Page 2 of 2)
from all existing Pulmatrix investors, including Polaris Venture Partners, 5AM Ventures, Arch Venture Partners, and Novartis Venture Fund, and will go to advancing Pulmatrix’s lead compound, PUR118, as a new treatment for cystic fibrosis and chronic obstructive pulmonary disease (COPD).
—Embera NeuroTherapeutics, based in Sudbury, MA and Shreveport, LA, took in $4.5 million in Series A funding, to put toward EMB-001, its treatment for nicotine and cocaine addiction. The money came from existing Embera backers, Louisiana Ventures, Louisiana Fund I, and Themelios Ventures, as well as other private investors.
—PeerTransfer, a Boston-based provider of a platform for online college tuition payments for international students, picked up $7.5 million. The Series A financing was led by Spark Capital and also included Accel Partners, Maveron, and Boston Seed Capital. That all comes on top of the $1.1 million PeerTransfer raised in seed funding last October, from Spark, Project 11 Ventures, and other angel investors. The money will go to new hires and infrastructure as PeerTransfer grows to work with more schools.
—New York- and Boston-headquartered BuyWithMe acquired another startup in the group buying space, Scoop St., which is focused on New York City local deals. No financial terms were disclosed, but this makes for BuyWithMe’s fifth acquisition this year.